Matthias Rath Selected Research

epigallocatechin gallate (epigallocatechin-3-gallate)

4/2006	Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
2/2005	Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
1/2005	In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
1/2004	Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Rath Research Topics

Disease

40	Neoplasms (Cancer) 06/2022 - 01/2004
23	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2005
9	Melanoma (Melanoma, Malignant) 01/2019 - 01/2006
4	Ovarian Neoplasms (Ovarian Cancer) 03/2017 - 04/2006
4	Breast Neoplasms (Breast Cancer) 09/2016 - 01/2005
4	Osteosarcoma (Osteogenic Sarcoma) 10/2013 - 02/2005
4	Lung Neoplasms (Lung Cancer) 06/2013 - 10/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2015
3	Fibrosarcoma 09/2016 - 01/2006
3	Atherosclerosis 01/2015 - 05/2010
3	Body Weight (Weight, Body) 04/2014 - 01/2007
3	Malignant Mesothelioma 06/2013 - 03/2006
2	Ascorbic Acid Deficiency (Vitamin C Deficiency) 01/2021 - 01/2021
2	Lyme Disease (Disease, Lyme) 01/2020 - 06/2016
2	Glioblastoma (Glioblastoma Multiforme) 03/2017 - 08/2014
2	Brain Neoplasms (Brain Tumor) 03/2017 - 08/2014
2	Inflammation (Inflammations) 09/2016 - 04/2014
2	Carcinogenesis 09/2016 - 07/2009
2	Carcinoma (Carcinomatosis) 07/2015 - 10/2006
2	Glioma (Gliomas) 08/2014 - 01/2007
2	Sarcoma (Soft Tissue Sarcoma) 10/2013 - 07/2013
2	Sepsis (Septicemia) 01/2013 - 11/2010
2	Infections 05/2011 - 01/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2006 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2005 - 01/2004
1	COVID-19 02/2022
1	Central Nervous System Cavernous Hemangioma 01/2021
1	Intellectual Disability (Idiocy) 01/2019
1	Pain (Aches) 01/2019
1	Disease Progression 08/2018
1	Fanconi Anemia (Fanconi's Anemia) 09/2016
1	Squamous Cell Carcinoma of Head and Neck 09/2016

Drug/Important Bio-Agent (IBA)

30	Matrix Metalloproteinases (MMPs)IBA 06/2017 - 01/2004
28	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021 - 01/2004
24	TeaIBA 01/2019 - 01/2005
23	Proline (L-Proline)FDA Link 01/2019 - 01/2004
23	Lysine (L-Lysine)FDA Link 01/2019 - 01/2004
18	Arginine (L-Arginine)FDA Link 07/2009 - 01/2004
15	matrigelIBA 09/2016 - 01/2004
9	GelatinasesIBA 08/2014 - 01/2005
8	Antineoplastic Agents (Antineoplastics)IBA 04/2014 - 01/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 01/2005
7	Peptide Hydrolases (Proteases)FDA Link 07/2015 - 12/2009
5	MicronutrientsIBA 09/2016 - 10/2006
5	Proteins (Proteins, Gene)FDA Link 09/2015 - 01/2005
5	Fibronectins (Fibronectin)IBA 09/2015 - 01/2005
5	FibrinIBA 08/2014 - 09/2012
5	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2014 - 09/2012
5	Therapeutic UsesIBA 03/2012 - 01/2005
4	QuercetinIBA 01/2019 - 03/2010
4	CytokinesIBA 06/2017 - 12/2009
4	Methylnitronitrosoguanidine (MNNG)IBA 10/2013 - 02/2005
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2006 - 01/2004
3	Lipoprotein(a)IBA 01/2021 - 01/2015
3	SeleniumIBA 03/2012 - 12/2005
3	CopperIBA 03/2012 - 12/2005
3	MucinsIBA 01/2006 - 01/2005
2	Pharmaceutical PreparationsIBA 06/2022 - 04/2014
2	VaccinesIBA 02/2022 - 05/2011
2	LipidsIBA 01/2021 - 01/2015
2	CollagenIBA 01/2021 - 09/2015
2	Matrix Metalloproteinase InhibitorsIBA 06/2017 - 03/2017
2	MitogensIBA 03/2017 - 12/2009
2	Amino Acids FDA Link 09/2016 - 11/2012
2	Capsules (Microcapsules)IBA 09/2015 - 01/2013
2	Tissue Inhibitor of Metalloproteinase-2IBA 08/2014 - 05/2013
2	Plasminogen Activators (Plasminogen Activator)IBA 08/2014 - 09/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2014 - 01/2007
2	Dihydrotachysterol (AT 10)IBA 01/2013 - 01/2007
2	phorbolIBA 03/2012 - 10/2006
2	EnzymesIBA 05/2011 - 01/2006
2	Apolipoproteins E (ApoE)IBA 07/2010 - 05/2010
2	Angiotensin IIIBA 07/2010 - 05/2010
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2010 - 01/2005
2	Cysteine (L-Cysteine)FDA Link 07/2009 - 12/2005
2	ManganeseIBA 07/2009 - 12/2005
2	Bovine Serum AlbuminIBA 01/2007 - 04/2006
2	Penicillins (Penicillin)FDA Link 04/2006 - 10/2005
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2006 - 02/2005
2	Streptomycin (Streptomycin Sulfate)FDA Link 04/2006 - 10/2005
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	AntioxidantsIBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 12/2020
1	Interleukin-2 (IL2)IBA 12/2020
1	LuteolinIBA 01/2020
1	IodineIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	monolaurinIBA 01/2020
1	baicaleinIBA 01/2020
1	Rosmarinic AcidIBA 01/2020
1	AcidsIBA 01/2020
1	Transfer RNA (tRNA)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019

Therapy/Procedure

7	Therapeutics 01/2019 - 01/2007
4	Drug Therapy (Chemotherapy) 10/2006 - 01/2005
2	Injections 04/2014 - 11/2006
2	Intraperitoneal Injections 03/2010 - 07/2009
1	Immunotherapy 12/2020